108 related articles for article (PubMed ID: 38853204)
1. TNIK in disease: from molecular insights to therapeutic prospects.
Wu X; Zhang Z; Qiu Z; Wu X; Chen J; Liu L; Liu X; Zhao S; Yang Y; Zhao Y
Apoptosis; 2024 Jun; ():. PubMed ID: 38853204
[TBL] [Abstract][Full Text] [Related]
2. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of traf2- and Nck-interacting kinase (TNIK) in polycystic ovary syndrome.
Li D; Jiao J; Zhou YM; Wang XX
Am J Transl Res; 2015; 7(6):1152-60. PubMed ID: 26279758
[TBL] [Abstract][Full Text] [Related]
4. The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1.
Wang M; Gu Y; Li Q; Feng B; Lv X; Zhang H; Kong Q; Dong Z; Tian X; Zhang Y
Genes Dis; 2024 May; 11(3):100997. PubMed ID: 38292191
[TBL] [Abstract][Full Text] [Related]
5. Fbxo3-Dependent Fbxl2 Ubiquitination Mediates Neuropathic Allodynia through the TRAF2/TNIK/GluR1 Cascade.
Lin TB; Hsieh MC; Lai CY; Cheng JK; Chau YP; Ruan T; Chen GD; Peng HY
J Neurosci; 2015 Dec; 35(50):16545-60. PubMed ID: 26674878
[TBL] [Abstract][Full Text] [Related]
6. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
7. Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase.
Read J; Collie IT; Nguyen-McCarty M; Lucaj C; Robinson J; Conway L; Mukherjee J; McCall E; Donohoe G; Flavell E; Peciak K; Warwicker J; Dix C; Van den Hoven BG; Madin A; Brown DG; Moss S; Haggarty SJ; Brandon NJ; Bürli RW
Bioorg Med Chem Lett; 2019 Aug; 29(15):1962-1967. PubMed ID: 31153805
[TBL] [Abstract][Full Text] [Related]
8. TNIK drives castration-resistant prostate cancer via phosphorylating EGFR.
Guo J; Liang J; Wang Y; Guo T; Liao Y; Zhong B; Guo S; Cao Q; Li J; Flores-Morales A; Niu Y; Jiang N
iScience; 2024 Jan; 27(1):108713. PubMed ID: 38226156
[TBL] [Abstract][Full Text] [Related]
9. Disease-associated synaptic scaffold protein CNK2 modulates PSD size and influences localisation of the regulatory kinase TNIK.
Zieger HL; Kunde SA; Rademacher N; Schmerl B; Shoichet SA
Sci Rep; 2020 Mar; 10(1):5709. PubMed ID: 32235845
[TBL] [Abstract][Full Text] [Related]
10. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
[TBL] [Abstract][Full Text] [Related]
11. LKB1 loss promotes colorectal cancer cell metastasis through regulating TNIK expression and actin cytoskeleton remodeling.
Hu G; Huang N; Zhang J; Zhang D; Wang S; Zhang Y; Wang L; Du Y; Kuang S; Ma K; Zhu H; Xu N; Liu M
Mol Carcinog; 2023 Nov; 62(11):1659-1672. PubMed ID: 37449799
[TBL] [Abstract][Full Text] [Related]
12. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.
Takahashi H; Ishikawa T; Ishiguro M; Okazaki S; Mogushi K; Kobayashi H; Iida S; Mizushima H; Tanaka H; Uetake H; Sugihara K
BMC Cancer; 2015 Oct; 15():794. PubMed ID: 26499327
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
Sekita T; Yamada T; Kobayashi E; Yoshida A; Hirozane T; Kawai A; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Matsumoto M; Nakamura M; Nakayama R; Masuda M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429395
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of TRAF2‑ and NCK‑interacting protein kinase (TNIK) and phosphorylated TNIK in papillary thyroid carcinoma.
Li J; Lan L; Xu Y; Liu S; Liu M; Hu G; Wu G; Zhao Y; Shi J; Wang J; Sun Y; Wang Z; Zhao R
Oncol Lett; 2023 Jul; 26(1):310. PubMed ID: 37332335
[TBL] [Abstract][Full Text] [Related]
17. TNIK's emerging role in cancer, metabolism, and age-related diseases.
Ewald CY; Pulous FE; Lok SWY; Pun FW; Aliper A; Ren F; Zhavoronkov A
Trends Pharmacol Sci; 2024 Jun; 45(6):478-489. PubMed ID: 38777670
[TBL] [Abstract][Full Text] [Related]
18. The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons.
Larhammar M; Huntwork-Rodriguez S; Rudhard Y; Sengupta-Ghosh A; Lewcock JW
J Neurosci; 2017 Nov; 37(46):11074-11084. PubMed ID: 28993483
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
20. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
